Mar 4, 2026 07:00AM
Jan 7, 2026 07:02AM
Jan 7, 2026 07:00AM
Dec 18, 2025 07:02AM
Dec 18, 2025 07:00AM
Dec 8, 2025 07:00AM
Dec 8, 2025 07:00AM Kamada Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates 2025 Full-Year Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2026
Nov 10, 2025 07:00AM
Nov 4, 2025 07:00AM
Nov 3, 2025 07:00AM
Oct 29, 2025 07:00AM
Sep 2, 2025 07:00AM
Aug 13, 2025 07:00AM
Aug 11, 2025 07:01AM Kamada receives FDA approval for Houston plasma collection center
Aug 11, 2025 07:00AM
Aug 6, 2025 07:00AM
Jun 17, 2025 07:00AM
May 14, 2025 07:00AM
May 7, 2025 07:00AM
May 5, 2025 07:00AM
Apr 22, 2025 10:00AM Kamada Expects Third Plasma Collection Site To Support Its Hyper-Immune Plasma Needs And Add Up To $10M In Annual Revenue At Full Capacity
Mar 24, 2025 07:00AM
Mar 19, 2025 07:03AM
Mar 19, 2025 07:00AM
Mar 5, 2025 07:05AM
Mar 5, 2025 07:00AM
Feb 28, 2025 09:00AM
Feb 26, 2025 07:00AM Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025
Jan 22, 2025 07:02AM
Jan 22, 2025 07:00AM
Jan 8, 2025 07:00AM
Nov 13, 2024 11:05AM
Nov 13, 2024 07:00AM
Nov 6, 2024 07:00AM
Nov 4, 2024 07:00AM Kamada to Present at the Stifel 2024 Healthcare Conference
Sep 23, 2024 07:00AM
Aug 14, 2024 07:00AM
Aug 7, 2024 07:00AM
May 8, 2024 07:00AM
May 1, 2024 07:00AM
Mar 6, 2024 07:05AM
Mar 6, 2024 07:05AM Kamada Issues 2024 CEO Letter to Shareholders
Mar 6, 2024 07:00AM
Feb 28, 2024 07:00AM
Dec 7, 2023 11:00AM
Dec 6, 2023 07:03AM
Dec 6, 2023 07:00AM
Nov 13, 2023 07:00AM
Nov 8, 2023 07:00AM Kamada to Announce Third Quarter and First Nine Months Ended September 30, 2023 Financial Results and Host Conference Call on November 13, 2023
Oct 16, 2023 07:03AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All